...
首页> 外文期刊>Chemical and Pharmaceutical Bulletin >2-(3-Pyridyl)thiazolidine-4-carboxamide derivatives. II. Structure-activity relationships and active configuration of 2-(3-pyridyl)thiazolidine-4-carboxamides as platelet-activating factor receptor antagonists.
【24h】

2-(3-Pyridyl)thiazolidine-4-carboxamide derivatives. II. Structure-activity relationships and active configuration of 2-(3-pyridyl)thiazolidine-4-carboxamides as platelet-activating factor receptor antagonists.

机译:2-(3-吡啶基)噻唑烷-4-羧酰胺衍生物。二。作为血小板活化因子受体拮抗剂的2-(3-吡啶基)噻唑烷-4-羧酰胺的结构活性关系和活性构型。

获取原文
获取原文并翻译 | 示例

摘要

Conversion of the 2-(3-pyridyl)thiazolidine part of 1-(3-phenylpropyl)-4-[2-(3-pyridyl)thiazolidine-4-carbonyl]piperazine (YM461), which is a potent platelet-activating factor (PAF) antagonist, to other rings was performed, and PAF antagonistic activities evaluated. The 2-(3-pyridyl)thiazolidine skeleton, which exists as a mixture of cis and trans diastereomers, played an important role in the potency of PAF antagonism. In this study, new effective skeletons were not uncovered, however, 2-(4-pyridyl)thiazolidine-4-carboxamides (1n and 1z) showed potent PAF antagonistic activities equal to the 3-pyridyl derivatives. From the results obtained for 1a, 1a(S), 1g and 1i, a cis-(2R,4R)-2-(3-pyridyl)thiazolidine-4-carboxamide was assumed to be the active configuration for PAF antagonism.
机译:1-(3-苯基丙基)-4- [2-(3-吡啶基)噻唑烷-4-羰基]哌嗪(YM461)的2-(3-吡啶基)噻唑烷部分(YM461)的转化对其他环进行(PAF)拮抗剂,并评价PAF拮抗活性。以顺式和反式非对映异构体的混合物形式存在的2-(3-吡啶基)噻唑烷骨架在PAF拮抗作用中发挥了重要作用。在这项研究中,没有发现新的有效骨架,但是,2-(4-吡啶基)噻唑烷-4-羧酰胺(1n和1z)显示出与3-吡啶基衍生物相当的有效PAF拮抗活性。从1a,1a(S),1g和1i获得的结果中,假定顺式-(2R,4R)-2-(3-吡啶基)噻唑烷-4-羧酰胺是PAF拮抗作用的活性构型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号